| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9916a6e9066d97f64b89bd309b48d1a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7076dedc2d2a657bb9fccb6f5dbf0296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5050f8a78737ea730347d5e3d039fd0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b0b71ccc86e787fa2a1bb879b03170
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27300ee320c711669b14600be4078d00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18405971d9568daeadac7a7bbb5550b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e573197ccb5a675cf58c3e74ad6507e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_289853f86dbfd202fe6c7251904bc40d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5044e7dd5764fc40989d3291a7458ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b74d5bcb03565571274b41ea755f660
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d8300ebafb2bcb1934a24310b5b048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6d8dbc3becc97dc36f2996b175b088b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3b1fc6b98f60084c486bda243dede2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa8b86f9735ff0f8e36844aea8d5ee2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a022f06bb41170bbd7bda54fa903fcf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3fe09a57790d8a07a9c694f96f83900
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eceaaa1554acbbf58d10a65e6bd44ed |
| publicationDate |
2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022144485-A1 |
| titleOfInvention |
Biomarkers and method for prediction or prognosis of the response to treatment with braf inhibitors and mek inhibitors (brafi + meki) |
| abstract |
Disclosed are: biomarkers and a method for the prediction or prognosis of the response to treatment with BRAF inhibitors and MEK inhibitors (BRAFi + MEKi) in patients with mutated BRAF metastatic melanoma; a kit or device; and the uses thereof. |
| priorityDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |